Targeting A2 adenosine receptors in cancer
Author:
Affiliation:
1. Centre de Recherche du, Centre Hospitalier de l’Université de Montréal, et Institut du Cancer de Montréal Montréal Québec Canada
2. Faculté de Pharmacie, Université de Montréal Montréal Québec Canada
Funder
Famille Jean-Guy Sabourin Research
Pharmacology of University of Montreal
La Vie en Rose
Fonds de Recherche du Québec-Santé
Publisher
Wiley
Subject
Cell Biology,Immunology,Immunology and Allergy
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1038/icb.2017.8
Reference95 articles.
1. Immunosuppressive activities of adenosine in cancer
2. CD73-Generated Adenosine: Orchestrating the Tumor-Stroma Interplay to Promote Cancer Growth
3. International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An Update
4. T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response
5. Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis
Cited by 85 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Nano-medicine therapy reprogramming metabolic network of tumour microenvironment: new opportunity for cancer therapies;Journal of Drug Targeting;2024-01-22
2. Metabolic advantages of regulatory T cells dictated by cancer cells;International Immunology;2023-10-14
3. Novel Immune Therapies for Renal Cell Carcinoma;Hematology/Oncology Clinics of North America;2023-10
4. Diverging prognostic effects of CD155 and CD73 expressions in locally advanced triple-negative breast cancer;Frontiers in Oncology;2023-07-13
5. Review immune response of targeting CD39 in cancer;Biomarker Research;2023-06-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3